Mandorfer, M <br/><br/>
Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels.  [electronic resource] 

 -  Journal of viral hepatitis  Jan 2014 
 - 33-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2893 
<br/><br/><label>Standard No.: </label>10.1111/jvh.12118  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Drug Therapy, Combination--methods<br/>Female<br/>HIV Infections--complications<br/>Hepatitis C, Chronic--diagnosis<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--therapeutic use<br/>Prognosis<br/>Prospective Studies<br/>Recombinant Proteins--therapeutic use<br/>Ribavirin--therapeutic use<br/>Treatment Failure<br/>gamma-Glutamyltransferase--blood